Phenolic constituents of medicinal plants with activity against trypanosoma brucei

Molecules

Volumn 21, Issue 4, 2016, Pages

  Sun, Ya Nan ^a   No, Joo Hwan ^b   Lee, Ga Young ^a   Li, Wei ^c   Yang, Seo Young ^a   Yang, Gyongseon ^b   Schmidt, Thomas J ^d   Kang, Jong Seong ^a   Kim, Young Ho ^a  

^a Chungnam National University   (South Korea)

^b Institute Pasteur Korea   (South Korea)

^c Yeungnam University   (South Korea)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Medicinal plants; Neglected tropical diseases; Phenolic constituents; QSAR; Trypanosoma brucei

Indexed keywords

ANTITRYPANOSOMAL AGENT; BIOLOGICAL PRODUCT; PHENOL DERIVATIVE;

ANIMAL; CHEMISTRY; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PARASITOLOGY; PATHOGENICITY; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

ANIMALS; BIOLOGICAL PRODUCTS; HUMANS; PHENOLS; PLANTS, MEDICINAL; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84968919971     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21040480     Document Type: Article

References (21)

1. Barrett, M.P. Problems for the chemotherapy of human African trypanosomiasis. Curr. Opin. Infect. Dis. 2000, 13, 647-651.
2. Olliario, P.; Lazdins, J.; Guhl, F. Developments in the treatment of leishmaniasis and trypanosomiasis. Expert Opin. Emerg. Drugs 2002, 7, 1-7.
3. Hannaert, V. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: Therapeutic targets and screening systems. Planta Med. 2011, 77, 586-597.
4. Kristjanson, P.M.; Swallow, B.M.; Rowlands, G.J.; Kruska, R.L.; De Leeuw, P.N. Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research. Agric. Syst. 1999, 59, 79-98.
5. Welburn, S.C.; Fèvre, E.M.; Coleman, P.G.; Odiit, M.; Maudlin, I. Sleeping sickness: A tale of two diseases. Trends Parasitol. 2001, 17, 19-24.
6. Simarro, P.P.; Cecchi, G.; Franco, J.R.; Paone, M.; Diarra, A.; Ruiz-Postigo, J.A.; Fèvre, E.M.; Mattioli, R.C.; Jannin, J.G. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl. Trop. Dis. 2012, 6, e1859.
7. WHO. Control and Surveillance of African Trypanosomiasis Report of a WHO Expert Committee. WHO Tech. Rep. Ser. 2013, 984, 1-250.
8. Kennedy, P.G.E. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann. Neurol. 2008, 64, 116-126.
9. Barrett, M.P. Potential new drugs for human African trypanosomiasis: Some progress at last. Curr. Opin. Infect. Dis. 2010, 23, 603-608.
10. Ferrins, L.; Rahmani, R.S.; and Baell, J.B. Drug discovery and human African trypanosomiasis: A disease less neglected. Future Med. Chem. 2013, 5, 1801-1841.
11. Docampo, R.; Moreno, S.N. Current chemotherapy of human African trypanosomiasis. Parasitol. Res. 2003, 90, S10-S13.
12. Pepin, J.; Milord, F. The treatment of human African trypanosomiasis. Adv. Parasitol. 1994, 33, 1-47.
13. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.A.; Biavatti, M.W.; Brun, R.; da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.G.; et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part I. Curr. Med. Chem. 2012, 19, 2128-2175.
14. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.A.; Biavatti, M.W.; Brun, R.; Da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.G.; et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part II. Curr. Med. Chem. 2012, 19, 2176-2228.
15. Tasdemir, D.; Kaiser, M.; Brun, R.; Yardley, V.; Schmidt, T.J.; Tosun, F.; Rüedi, P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: In Vitro, in Vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob. Agents Chemother. 2006, 50, 1352-1364.
16. Changtam, C.; De Koning, H.P.; Ibrahim, H.; Sajid, M.S.; Gould, M.K.; Suksamrarn, A. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur. J. Med. Chem. 2010, 45, 941-956.
17. MOE-Molecular Operating Environment v. 2014.0901. For details on molecular descriptors see: http://www.chemcomp.com/journal/descr.htm. Available from Chemical Computing Group, Montreal, Canada: http://www.chemcomp.com/journal/descr.htm.
18. Schmidt, T.J.; Heilmann, J. Quantitative Structure-Cytotoxicity Relationships of Sesquiterpene Lactones derived from Partial Charge (Q)-based Fractional Accessible Surface Area Descriptors (Q-frASAs). Quant. Struct. Act. Relat. 2002, 21, 276-287.
19. Cruciani, G.; Crivori, P.; Carrupt, P.-A.; Testa, B. Molecular fields in quantitative structure-permeation relationships: The VolSurf approach. J. Mol. Struct. 2000, 503, 17-30.
20. Thao, N.P.; No, J.H.; Luyen, B.T.T.; Yang, G.; Byun, S.Y.; Goo, J.; Kim, K.T.; Cuong, N.X.; Nam, N.H.; Minh, C.V.; Schmidt, T.J.; Kang, J.S.; Kim, Y.H. Secondary metabolites from vietnamese marine invertebrates with activity against Trypanosoma brucei and T. cruzi. Molecules 2014, 19, 7869-7880.
21. Thao, N.P.; Luyen, B.T.T.; Brun, R.; Kaiser, M.; Kiem, P.V.; Minh, C.V.; Schmidt, T.J.; Kang, J.S.; Kim, Y.H. Anti-protozoal activities of cembrane-type diterpenes from Vietnamese soft Corals. Molecules 2015, 20, 12459-12468.